UBS Group’s ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN MTUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.5K | Buy |
67
+30
| +81% | +$1.59K | ﹤0.01% | 9041 |
|
|
2026
Q1 | $1.25K | Buy |
37
+13
| +54% | +$490 | ﹤0.01% | 9572 |
|
|
2025
Q4 | $905 | Buy |
24
+23
| +2,300% | +$876 | ﹤0.01% | 9766 |
|
|
2025
Q3 | $39 | Hold |
1
| – | – | ﹤0.01% | 10051 |
|
|
2025
Q2 | $36 | Hold |
1
| – | – | ﹤0.01% | 10077 |
|
|
2025
Q1 | $28 | Hold |
1
| – | – | ﹤0.01% | 10059 |
|
|
2024
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 9749 |
|
|
2024
Q3 | $29 | Hold |
1
| – | – | ﹤0.01% | 9281 |
|
|
2024
Q2 | $28 | Hold |
1
| – | – | ﹤0.01% | 9281 |
|
|
2024
Q1 | $26 | Hold |
1
| – | – | ﹤0.01% | 9005 |
|
|
2023
Q4 | $19 | Hold |
1
| – | – | ﹤0.01% | 9074 |
|
|
2023
Q3 | $15 | Hold |
1
| – | – | ﹤0.01% | 9166 |
|
|
2023
Q2 | $16 | Sell |
1
-10,879
| -100% | -$168K | ﹤0.01% | 8709 |
|
|
2023
Q1 | $165K | Buy |
10,880
+8,398
| +338% | +$131K | ﹤0.01% | 5539 |
|
|
2022
Q4 | $41.8K | Buy |
2,482
+2,090
| +533% | +$34.7K | ﹤0.01% | 6938 |
|
|
2022
Q3 | $5K | Hold |
392
| – | – | ﹤0.01% | 9208 |
|
|
2022
Q2 | $6K | Buy |
+392
| New | +$6.83K | ﹤0.01% | 8700 |
|
UBS Group's MTUL Position: Q2 2026 in Review
UBS Group increased its ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) stake by 81% in Q2 2026, buying an estimated $1.59K and bringing the position to 67 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #9041.
UBS Group first reported a position in MTUL in Q2 2022 and has held it in 17 quarters since. The position peaked at $165K in Q1 2023. 1 fund tracked by Wall St. Rank holds MTUL as of Q2 2026.
- UBS Group held 67 shares of ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN worth $4.5K as of Q2 2026.
- UBS Group bought 30 ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN shares in Q2 2026, an estimated $1.59K.
- ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9041 holding.
- UBS Group first reported a position in ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN in Q2 2022 and has held it in 17 quarters since.
- UBS Group's ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN position peaked at $165K in Q1 2023.
- 1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.